Hepion Pharmaceuticals, Inc.
HEPA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583771
In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Other share classesCTRVP
13F holders, Q2 2024
Institutional positions in Hepion Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −1 vs. Q1 2024
- Shares held
- 841.7K
- +130.0K (+18.3%) vs. Q1 2024
- Total value
- $863.9K
- −$908.1K (−51.2%) vs. Q1 2024
- New holders
- 1
- 6 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HEPA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 4 | $1.39K |
| Q1 2025 | 16 | $419.7K |
| Q4 2024 | 22 | $215.4K |
| Q3 2024 | 22 | $338.2K |
| Q2 2024 | 24 | $863.9K |
| Q1 2024 | 25 | $1.77M |
| Q4 2023 | 24 | $2.42M |
| Q3 2023 | 24 | $4.00M |
| Q2 2023 | 23 | $5.43M |
| Q1 2023 | 32 | $5.60M |
| Q4 2022 | 32 | $2.20M |
| Q3 2022 | 32 | $3.61M |
| Q2 2022 | 34 | $4.24M |
| Q1 2022 | 38 | $9.74M |
| Q4 2021 | 43 | $9.00M |
| Q3 2021 | 42 | $11.9M |
| Q2 2021 | 49 | $21.3M |
| Q1 2021 | 45 | $14.7M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Hepion Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 516,000 | $526.4K | 0.01% | +126,000+32.3% | Added |
| Vanguard Group Inc | 127,649 | $130.2K | 0.00% | −29,711−18.9% | Reduced |
| BlackRock Inc. | 82,954 | $84.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 44,543 | $48.1K | 0.00% | +5,710+14.7% | Added |
| State Street Corp | 15,676 | $16.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 14,638 | $15.8K | 0.00% | +30.0% | Added |
| Royal Bank of Canada | 14,520 | $15.0K | 0.00% | +14,500+72,500.0% | Added |
| XTX Topco Ltd | 10,161 | $11.0K | 0.00% | +10,161 | New |
| The PNC Financial Services Group, Inc. | 7,724 | $7.88K | 0.00% | −155−2.0% | Reduced |
| Tower Research Capital LLC (TRC) | 5,806 | $5.92K | 0.00% | +3,906+205.6% | Added |
| Morgan Stanley | 1,357 | $1.38K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 175 | $179 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 113 | $115 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 84 | $91 | 0.00% | −255−75.2% | Reduced |
| AdvisorNet Financial, Inc | 88 | $90 | 0.00% | −88−50.0% | Reduced |
| Macquarie Group Ltd | 88 | $90 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 70 | $71 | 0.00% | −113−61.7% | Reduced |
| Bank of America Corp | 46 | $47 | 0.00% | +45+4,500.0% | Added |
| Barclays PLC | 16 | $16 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Benjamin F. Edwards & Company, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −11−100.0% | Sold out |